
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenues | $9.47B+2.3% | $9.26B+8.3% | $8.54B+5.7% | $8.08B+3.9% | $7.78B+16.5% | $6.67B+6.6% | $6.26B+7.5% | $5.83B+9.8% | $5.31B |
| Cost of Sales | $2.67B-1.9% | $2.72B+6.2% | $2.56B+4.4% | $2.45B+6.6% | $2.30B+12.0% | $2.06B+3.3% | $1.99B+4.2% | $1.91B+7.7% | $1.77B |
| Selling, general and administrative expenses | $2.38B+2.6% | $2.32B+7.8% | $2.15B+7.1% | $2.01B+0.4% | $2.00B+15.9% | $1.73B+5.4% | $1.64B+10.4% | $1.48B+11.2% | $1.33B |
| Research and development expenses | $698.0M+1.7% | $686.0M+11.7% | $614.0M+13.9% | $539.0M+6.1% | $508.0M+9.7% | $463.0M+1.3% | $457.0M+5.8% | $432.0M+13.1% | $382.0M |
| Amortization of intangible assets | $128.0M-9.2% | $141.0M-5.4% | $149.0M-0.7% | $150.0M-6.8% | $161.0M+0.6% | $160.0M+3.2% | $155.0M+32.5% | $117.0M+28.6% | $91.0M |
| Restructuring charges and certain acquisition and divestiture-related costs | $51.0M-3.8% | $53.0M+0.0% | $53.0M+381.8% | $11.0M | — | — | — | — | — |
| Interest expense, net of capitalized interest | $222.0M-1.3% | $225.0M-5.9% | $239.0M+8.1% | $221.0M-1.3% | $224.0M-3.0% | $231.0M+3.6% | $223.0M+8.3% | $206.0M+17.7% | $175.0M |
| Other (income)/deductions––net | -$36.0M-89.5% | -$19.0M+88.1% | -$159.0M-497.5% | $40.0M-16.7% | $48.0M+182.4% | $17.0M+129.8% | -$57.0M+31.3% | -$83.0M-1483.3% | $6.0M |
| Income before provision for taxes on income | $3.36B+7.2% | $3.13B+6.7% | $2.94B+10.5% | $2.66B+6.8% | $2.49B+24.6% | $2.00B+10.8% | $1.80B+6.6% | $1.69B+10.8% | $1.52B |
| Provision for taxes on income | $687.0M+7.8% | $637.0M+6.9% | $596.0M+9.4% | $545.0M+20.0% | $454.0M+26.1% | $360.0M+19.6% | $301.0M+13.2% | $266.0M-59.9% | $663.0M |
| Net income before allocation to noncontrolling interests | $2.67B+7.1% | $2.50B+6.7% | $2.34B+10.8% | $2.11B+3.8% | $2.03B+24.3% | $1.64B+9.1% | $1.50B+5.3% | $1.42B+65.2% | $862.0M |
| Less: Net income/(loss) attributable to noncontrolling interests | $0-100.0% | $10.0M+350.0% | -$4.0M-33.3% | -$3.0M+0.0% | -$3.0M-50.0% | -$2.0M | $0+100.0% | -$4.0M-100.0% | -$2.0M |
| Net income attributable to Zoetis Inc. | $2.67B+7.5% | $2.49B+6.1% | $2.34B+10.9% | $2.11B+3.8% | $2.04B+24.4% | $1.64B+9.2% | $1.50B+5.0% | $1.43B+65.3% | $864.0M |
| Basic (in dollars per share) | $6030000.00+10.2% | $5470000.00+7.7% | $5080000.00+12.6% | $4510000.00+5.1% | $4290000.00+124709202.3% | $3.44+9.6% | $3.14+6.1% | $2.96+68.2% | $1.76 |
| Diluted (in dollars per share) | $6020000.00+10.1% | $5470000.00+7.9% | $5070000.00+12.9% | $4490000.00+5.2% | $4270000.00+124853701.2% | $3.42+10.0% | $3.11+6.1% | $2.93+67.4% | $1.75 |
| Basic (in shares) | 443.44B-2.4% | 454.20B-1.5% | 461.17B-1.6% | 468.89B-1.2% | 474.35B+99657.3% | 475.5M-0.5% | 478.1M-1.0% | 483.1M-1.4% | 489.9M |
| Diluted (in shares) | 443.83B-2.4% | 454.85B-1.6% | 462.27B-1.7% | 470.38B-1.3% | 476.72B+99513.0% | 478.6M-0.7% | 481.8M-1.0% | 486.9M-1.3% | 493.2M |
| Dividends declared per common share | $2030000.00+13.0% | $1796000.00+15.4% | $1557000.00+15.3% | $1350000.00+25.6% | $1075000.00+126470488.2% | $0.85+22.8% | $0.69+27.7% | $0.54+22.9% | $0.44 |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.